nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Verteporfin—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Verteporfin—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Verteporfin—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Verteporfin—Influenza—Triamcinolone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Verteporfin—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Verteporfin—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Verteporfin—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Verteporfin—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Verteporfin—Muscular weakness—Betamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Verteporfin—Osteoarthritis—Prednisone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Verteporfin—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Verteporfin—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Verteporfin—Haemoglobin—Prednisolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Verteporfin—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Verteporfin—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Verteporfin—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Verteporfin—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Verteporfin—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Verteporfin—Sweating—Methylprednisolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Verteporfin—Visual impairment—Prednisolone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Verteporfin—Muscular weakness—Prednisone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Verteporfin—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Verteporfin—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Verteporfin—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Verteporfin—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Verteporfin—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Verteporfin—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Verteporfin—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Verteporfin—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Verteporfin—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Verteporfin—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Verteporfin—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Verteporfin—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Verteporfin—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Verteporfin—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Verteporfin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Verteporfin—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Verteporfin—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Verteporfin—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Verteporfin—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Verteporfin—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Verteporfin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Verteporfin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Verteporfin—Vision blurred—Prednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Verteporfin—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Verteporfin—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Verteporfin—Visual impairment—Betamethasone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Verteporfin—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Verteporfin—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Verteporfin—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Verteporfin—Malaise—Prednisolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Verteporfin—Vertigo—Prednisolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Verteporfin—Syncope—Prednisolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Verteporfin—Eye disorder—Betamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Verteporfin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Verteporfin—Back pain—Triamcinolone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Verteporfin—Angiopathy—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Verteporfin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Verteporfin—Hypertension—Prednisolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Verteporfin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Verteporfin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Verteporfin—Discomfort—Prednisolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Verteporfin—Haemoglobin—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Verteporfin—Haemorrhage—Prednisone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Verteporfin—Malaise—Triamcinolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Verteporfin—Malaise—Methylprednisolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Verteporfin—Vertigo—Triamcinolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Verteporfin—Syncope—Triamcinolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Verteporfin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Verteporfin—Syncope—Methylprednisolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Verteporfin—Oedema—Prednisolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Verteporfin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Verteporfin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Verteporfin—Shock—Prednisolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Verteporfin—Cough—Triamcinolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Verteporfin—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Verteporfin—Hypertension—Triamcinolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Verteporfin—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Verteporfin—Pneumonia—Methotrexate—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Verteporfin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Verteporfin—Eye disorder—Prednisone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Verteporfin—Flushing—Prednisone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Verteporfin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Verteporfin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Verteporfin—Discomfort—Triamcinolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Verteporfin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Verteporfin—Angiopathy—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Verteporfin—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Verteporfin—Immune system disorder—Prednisone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Verteporfin—Malaise—Betamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Verteporfin—Malaise—Dexamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Verteporfin—Oedema—Triamcinolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Verteporfin—Vertigo—Dexamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Verteporfin—Vertigo—Betamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Verteporfin—Syncope—Betamethasone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Verteporfin—Syncope—Dexamethasone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Verteporfin—Sweating—Methotrexate—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Verteporfin—Shock—Triamcinolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Verteporfin—Shock—Methylprednisolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Verteporfin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Verteporfin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Verteporfin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Verteporfin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Verteporfin—Malnutrition—Prednisone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Verteporfin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Verteporfin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Verteporfin—Hypertension—Dexamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Verteporfin—Hypertension—Betamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Verteporfin—Discomfort—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Verteporfin—Discomfort—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Verteporfin—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Verteporfin—Pain—Prednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Verteporfin—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Verteporfin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Verteporfin—Vision blurred—Prednisone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Verteporfin—Oedema—Dexamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Verteporfin—Oedema—Betamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Verteporfin—Visual impairment—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Verteporfin—Anaemia—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Verteporfin—Shock—Dexamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Verteporfin—Shock—Betamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Verteporfin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Verteporfin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Verteporfin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Verteporfin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Verteporfin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Verteporfin—Malaise—Prednisone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Verteporfin—Vertigo—Prednisone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Verteporfin—Syncope—Prednisone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Verteporfin—Urticaria—Prednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Verteporfin—Pain—Triamcinolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Verteporfin—Hypertension—Prednisone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Verteporfin—Arthralgia—Prednisone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Verteporfin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Verteporfin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Verteporfin—Discomfort—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Verteporfin—Urticaria—Triamcinolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Verteporfin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Verteporfin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Verteporfin—Oedema—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Verteporfin—Back pain—Methotrexate—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Verteporfin—Shock—Prednisone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Verteporfin—Pain—Betamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Verteporfin—Pain—Dexamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Verteporfin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Verteporfin—Skin disorder—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Verteporfin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Verteporfin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Verteporfin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Verteporfin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Verteporfin—Malaise—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Verteporfin—Urticaria—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Verteporfin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Verteporfin—Dizziness—Prednisolone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Verteporfin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Verteporfin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Verteporfin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Verteporfin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Verteporfin—Pruritus—Triamcinolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Verteporfin—Cough—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Verteporfin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Verteporfin—Rash—Prednisolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Verteporfin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Verteporfin—Headache—Prednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Verteporfin—Constipation—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Verteporfin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Verteporfin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Verteporfin—Asthenia—Betamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Verteporfin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Verteporfin—Nausea—Prednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Verteporfin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Verteporfin—Pruritus—Betamethasone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Verteporfin—Rash—Triamcinolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Verteporfin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Verteporfin—Rash—Methylprednisolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Verteporfin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Verteporfin—Urticaria—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Verteporfin—Headache—Triamcinolone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Verteporfin—Headache—Methylprednisolone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Verteporfin—Body temperature increased—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Verteporfin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Verteporfin—Dizziness—Betamethasone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Verteporfin—Nausea—Triamcinolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Verteporfin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Verteporfin—Rash—Dexamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Verteporfin—Rash—Betamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Verteporfin—Dermatitis—Betamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Verteporfin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Verteporfin—Headache—Dexamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Verteporfin—Headache—Betamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Verteporfin—Asthenia—Prednisone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Verteporfin—Pain—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Verteporfin—Pruritus—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Verteporfin—Nausea—Betamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Verteporfin—Nausea—Dexamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Verteporfin—Dizziness—Prednisone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Verteporfin—Rash—Prednisone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Verteporfin—Dermatitis—Prednisone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Verteporfin—Headache—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Verteporfin—Nausea—Prednisone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—ankylosing spondylitis	0.000965	0.000965	CcSEcCtD
Verteporfin—Rash—Methotrexate—ankylosing spondylitis	0.00092	0.00092	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000919	0.000919	CcSEcCtD
Verteporfin—Headache—Methotrexate—ankylosing spondylitis	0.000914	0.000914	CcSEcCtD
Verteporfin—Nausea—Methotrexate—ankylosing spondylitis	0.000866	0.000866	CcSEcCtD
